BIOTW

Biotech Acquisition Company

Price

$0.02

return (12m)

p/e

0.03

p/bv

0.23

DIVIDEND YIELD

0.00%

BIOTW price

Biotech Acquisition

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BIOTW

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

-97.60%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals BIOTW

Valuation

P/E

0.03

Sector -140.53

Industry -1,485.33

P/BV

0.23

Sector -9.63

Industry -42.81

P/Revenue (PSR)

Sector -11.62

Industry -

EV/EBITDA

Sector -951.63

Industry -

EV/EBIT

Sector -5,119,948,974.90

Industry -

P/EBITDA

0.04

Sector -104.90

Industry -462.41

P/EBIT

0.04

Sector -122.92

Industry -440.03

P/Total Assets

0.15

Sector 0.14

Industry 0.41

P/Net Current Assets

0.67

Sector -7.17

Industry -

P/Working Capital

0.51

Sector -

Industry -

EPS

0.53

Sector -9,570.30

Industry -20,676.42

BVPS

0.08

Sector -24,760.99

Industry -45,697.75

Efficiency

Gross Margin

0.00%

Sector 0.85%

Industry -0.03%

EBITDA Margin

Sector -111.21%

Industry -

EBIT Margin

Sector -865,723.39%

Industry -

Operating Margin

0.00%

Sector -7.11%

Industry -10.83%

Net Profit Margins

0.00%

Sector -2.49%

Industry -11.89%

Asset Turnover

0.00

Sector 0.01

Industry -

Profitability

ROE

663.31%

Sector -1,326.47%

Industry -67.53%

ROA

448.03%

Sector -8.23%

Industry -16.16%

ROIC

0.00%

Sector -12.28%

Industry -

Dividends

Dividend yield

0.00%

Sector 0.26%

Industry -

Payout

0.00%

Sector 5.58%

Industry -

Debt

Current Ratio

2.21

Sector -

Industry -

Net Debt / EBITDA

Sector -151.09

Industry -15.37

Net Debt / EBIT

Sector -22,751,088,854.40

Industry -17.44

Net Debt / Equity

-0.10

Sector -0.84

Industry -0.62

Gross Debt / Equity

0.00

Sector -0.23

Industry -0.89

Equity/Assets

0.68

Sector -0.03

Industry -0.11

Liabilities/Assets

0.32

Sector 0.37

Industry -0.01

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals BIOTW

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Biotech Acquisition ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$0.02

Fair Value

$0.98

Upside

6,081.83%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BIOTW Biotech Acquisition Company	$0.02	-	0.00%	0.03	0.23	663.31%	0.00%
HRZN Horizon Technology Finance Corporation	$4.60	-6.28%	24.10%	59.04	0.72	1.21%	-100.00%
ARCC Ares Capital Corporation	$19.26	1.59%	10.07%	14.26	0.99	6.91%	55.46%
GAIN Gladstone Investment Corporation	$15.68	19.46%	6.14%	3.77	0.96	25.53%	100.00%
BKCC BlackRock Capital Investment Corporation	$0.00	-	10.81%	9.46	0.86	9.04%	80.08%
RILYT B. Riley Financial Inc.	$21.50	65.08%	7.31%	1.34	3.12	231.65%	41.15%
WHF WhiteHorse Finance Inc.	$7.02	17.36%	16.86%	19.30	0.60	3.09%	16.60%
RILYN B. Riley Financial Inc.	$25.25	27.76%	6.44%	1.65	3.83	231.65%	41.15%
BEN Franklin Resources Inc.	$32.14	46.39%	4.00%	15.16	1.31	8.62%	11.94%
FDUS Fidus Investment Corporation	$19.44	4.73%	8.64%	9.32	0.98	10.47%	67.26%
SLRC SLR Investment Corp.	$11.67	-17.34%	12.36%	8.62	0.65	7.51%	-100.00%
MSCI MSCI Inc.	$540.30	-3.65%	1.44%	29.65	-14.97	-50.49%	40.74%
BANX StoneCastle Financial Corp.	$19.97	-0.13%	12.39%	4.00	0.81	20.19%	85.49%
GLAD Gladstone Capital Corporation	$19.34	-2.58%	9.52%	8.95	0.89	9.91%	65.72%
VRTS Virtus Investment Partners Inc.	$130.97	-27.13%	7.32%	7.31	0.92	12.66%	14.52%
TRIN Trinity Capital Inc.	$17.61	30.47%	13.62%	11.18	1.25	11.16%	58.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BIOTW Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Biotech Acquisition

Biotech Acquisition Company

Average Investor10 user rating

4.0 (1 people)

United States

6 years

Founded: 2020

2021

Time since IPO - 5 years

-

Employees

Biotech Acquisition Company (United States) is listed on the Nasdaq and has a market capitalization of $529.00 Thousand, with shareholders equity totaling $2.31 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Biotech Acquisition Company reported $- in revenue, generating net income of $15.32 million.

Key financial metrics include a P/E ratio of 0.03, a price-to-book (P/B) ratio of 0.23, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BIOTW.

Market cap

$529.00 Thousand

Net worth

$2.31 million

$2,310,000.00

Assets

$3.42 million

$3,420,000.00

Total Shares Outstanding

28.75 million

28,750,000

Average Daily Trading Volume

Sector

Financial

Industry

Capital Markets

BIOTW

BIOTW revenue and profits

Financial Results BIOTW

DRAG THE FRAME TO SEE MORE DATA

BIOTW cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BRK-A - Berkshire Hathaway

$751,911.88 --0,30% (12M)

P/E

12.68

0.00%

ROE

11.45%

P/BV

1.45

BRK-B - Berkshire Hathaway

$501.37 --0,27% (12M)

P/E

12.65

0.00%

ROE

11.46%

P/BV

1.45

JPM - JPMorgan

$333.20 8,19% (12M)

P/E

14.10

1.76%

ROE

17.37%

P/BV

2.45

BAC - Bank of America

$54.72 8,33% (12M)

P/E

12.51

2.05%

ROE

10.97%

P/BV

1.37

C - Citigroup

$130.27 31,06% (12M)

P/E

13.84

1.84%

ROE

7.94%

P/BV

1.10

ING - ING Group

$35.65 42,80% (12M)

P/E

4.82

3.67%

ROE

22.36%

P/BV

1.08

SNEX - StoneX Group

$65.17 45,30% (12M)

P/E

14.70

0.00%

ROE

18.53%

P/BV

2.72

GS - Goldman Sachs

$906.16 15,52% (12M)

P/E

15.43

1.66%

ROE

16.52%

P/BV

2.55